Products with Hepatoprotective bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2932 | Mauritianin |
| 1. Mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors. 2. Mauritianin has statistically significant cytoprotective activity similar to that of silymarin, tested at 60 ug/mL. | |
| BCN2933 | Alcesefoliside |
| 1. Alcesefoliside has statistically significant cytoprotective activity similar to that of silymarin, tested at 60 ug/mL. | |
| BCN2939 | Cassiaside |
| 1. Cassiaside and emodi show mixed-type inhibition against β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1). 2. Cassiaside demonstrates significant antimutagenic activity. 3. Cassiaside shows 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical scavenging effect. 4. Cassiaside has significant hepato-protective effects against galactosamine damage, which is higher than that of silybin from Silybum marianum. | |
| BCN2952 | Hispidulin 7-O-neohesperidoside |
| 1. Hispidulin 7-O-neohesperidoside is one of the active substances responsible for the protective effects of this plant. | |
| BCN2979 | Isoastragaloside I |
| Isoastragaloside I may be promising in modulating CCl4-induced lethality and most of its toxic effects. Astragaloside II and Isoastragaloside I are sufficient to ameliorate insulin resistance, they may provide the lead as a novel class of therapeutics for obesity-related diseases. | |
